17-alpha Hydroxyprogesterone caproate, commonly given to prevent recurrent preterm birth, is not effective for prevention and may increase the risk of gestational diabetes, according to a study in the American Journal of Obstetrics & Gynecology. Read more
Drug given to prevent recurrent preterm birth not effective
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
